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Abstract
Introduction: The selected factors connected with the heart 
donor may influence the extent of the harvested heart injury. 
Aim of the study: To assess the influence of selected factors 
connected with heart donor on troponin I levels in the periope-
rative period (from day 0 to day 3).
Material and methods: Retrospective analysis included 30 
patients (4 females, 26 males) aged 22 to 62 years, average 
48.5 ±11.00. The study group consisted of the patients whose 
hearts were harvested according to the same scheme. In all 
patients, troponin I levels were measured on the consecutive 
days after HTX.
The following features were analyzed: donor’s age, cause of 
donor’s death, vasopressants’ use and total ischemic time 
(TIT). Troponin I levels were measured by one step immunoen-
zymatic test (normal values up to 0.1 ng/ml).
Results: A inverse significant correlation between TIT (mean 
218.8 min ±44.2) and troponin I levels in the period between 
day 0 and two days after HTX was observed. No influence of 
vasopressants on troponin I levels was noted. The weak trend 
towards (r = 0.3; p = 0.17) the positive correlation between 
donor’s age and troponin I levels on the 1st day after HTX was 
observed. Similarly, the weak trend towards the positive cor-
relation between stroke and higher troponin I levels on the 1st 
postoperative day (p = 0.16) was observed.
Conclusion: TIT does not correlate positively with increased 
troponin I values. The relationship demands further analysis. 
The donor’s age and stroke as the cause of the donor’s death 
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Streszczenie
Wstęp: Wybrane czynniki związane z dawcą serca mogą wpły-
wać na stopień uszkodzenia pobranego od dawcy serca.
Cel pracy: Ocena wpływu wybranych czynników związanych 
z dawcą serca na wartości poziomów troponiny I w okresie 
okołooperacyjnym (od zerowej do trzeciej doby włącznie).
Materiał i metody: Analizą retrospektywną objęto 30 chorych 
(4 kobiety, 26 mężczyzn) w wieku 22–62 lat, średnio 48,5 ±11,0. 
Badaną grupę stanowili pacjenci, których serca pobierane były 
wg identycznego schematu i u których zmierzono stężenia tropo-
niny I w kolejnych dobach po transplantacji serca. Analizie pod-
dano: wiek dawcy, przyczynę zgonu dawcy, rodzaj leków wspo-
magających układ krążenia dawcy, całkowity czas niedokrwienia. 
Oceniono wpływ wybranych parametrów na stężenie troponiny I 
w okresie okołooperacyjnym mierzonego metodą jednostopnio-
wego testu immunoenzymatycznego (norma od 0,1 ng/ml).
Wyniki: Stwierdzono ujemną istotną statystycznie korelację po-
między całkowitym czasem niedokrwienia (średnio 218,8 min 
±44,2) a stężeniami troponiny I w okresie od zerowej do drugiej 
doby po transplantacji serca. Nie stwierdzono wpływu leków wa-
zopresyjnych na stężenia troponiny I. Wykazano słabą tendencję 
(r = 0,3; p = 0,17) do dodatniej korelacji pomiędzy wiekiem dawcy 
serca a stężeniami troponiny I w pierwszej dobie po transplantacji 
serca. Podobnie wykazano słabą tendencję w zależności pomię-
dzy obecnością udaru mózgu a wyższymi wartościami stężeń tro-
poniny I w pierwszej dobie (p = 0,16).
Wnioski: Całkowity czas niedokrwienia nie koreluje dodatnio ze 
wzrostem wartości troponiny I w pierwszych dobach po trans-
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Introduction
Given the chronic lack of donors (in Poland and worl-
dwide), development of surgical methods of the end stage 
heart failure treatment was observed [1]. 
However the proposed methods (“undersize” mitral an-
nuloplasty, surgical ventricular reconstruction and others) 
did not obtain first class recommendation in the available 
guidelines. Despite lack of control studies, heart transplan-
tation (HTX) is thought to significantly increase survival, 
exercise capacity, return to work, and quality of life compa-
red with conventional treatment. According to ESC (Europe-
an Society of Cardiology) guidelines, HTX gets the first class 
of recommendation with level of evidence C [2]. 
Half-life time in adult cardiac recipients currently exce-
eds 10 years. However perioperative mortality is still relati-
vely high, rating 10-20%. The most frequent from all cause 
of death in that period is the primary graft failure (40%) [3].
Because of chronic lack of donors, more and more often 
organs from “marginal donors” must be accepted. Accor-
ding to ISHLT guidelines, ischemic time > 4 hours, donor 
age > 45 years or high doses of vasopressing agents are the 
factors predisposing to early graft failure [4].
Analysis of the transplanted heart injury markers in the 
early period after heart transplantation serves a purpose.
Troponin is built of actin filaments and is bound with 
tropomiozin C. It is functionally connected with contrac-
tion of skeletal and heart muscles. Structurally, troponin is 
a complex of three proteins.
Troponin I, which connects with actin and stabilizes 
troponin-tropomiozin complex, is a very sensitive, and no-
wadays, popular marker of cardiac damage. An increased 
troponin level not only points out to myocardial infarction 
(guidelines for the diagnosis of myocardial infarction) but is 
also observed during every myocardial damage (even if is 
relatively small). Moreover, troponin levels should correlate 
with the extent of myocardial damage, and repeated measu-
rements allow for the observation of damage dynamics [5-7].
Measure of the extent of harvested heart injury may be 
the analysis of dynamics of troponin level changes in the 
particular periods after organ transplantation.
The hitherto papers have not presented explicit data 
concerning the role of troponin release after HTX and the 
influence of e.g. ischemic time on troponin levels, which 
justifies continuation of the studies [8-10].
Material and methods
30 patients (4 females, 26 males) were analyzed re-
trospectively, age: 22 to 62 years, average: 48.5 ±11.0. The 
study population consisted of the patients with the hearts 
harvested by the same surgeon (the first author) according 
to the same protection scheme using CELSIOR cardioplegic 
solution. All the patients had troponin I levels measured on 
the following days after HTX (when more than one value 
a day was present, the highest value of the day was used in 
the statistical analysis).
The following parameters were analysed: donor’s age, 
cause of donor’s death (stroke/trauma), use of vasopres-
sive agents (dopamine/dobutamine, norepinephrine), total 
ischemic time (TIT). The influence of chosen parameters on 
troponin I levels in the perioperative period was assessed. 
Troponin I was measured using one-step immunoenzymatic 
method (normal values to 0.1 ng/ml).
Myocardial protection
CELSIOR, a widely accepted cardioplegic solution, was 
routinely used for donor heart protection in all the cases. 
The most important  components of this solution, which 
enhanced the “protective power” are the following: manni-
tol, lactobionic acid, glutamic acid, histidine, calcium chlori-
de, potassium chloride (15 mmol) and magnesium chloride. 
The solution is slightly alkaline (pH = 7.3), slightly hyper-
tonic (242-368 mOsmol/L) with low viscosity (1.15 cSt), 
and has a high buffering capacity (acidic approximately 
11 mmol, alkaline approximately 7 mmol).
During harvesting the donor heart was arrested with 
2 liters of CELSIOR cardioplegic solution given directly into 
the aortic bulb. At the same time, the heart was topically 
cooled by the cold salin (NaCl 0.9%) solution with crashed 
ice. After excision of the heart, another, third liter of the 
CELSIOR solution was given into the aortic bulb. After the 
careful inspection of the explanted heart, and exclusion of 
the pathologies, the heart was placed in the same cardio-
plegic solution in at least 10 degrees Celsius to avoid fre-
ezing of the heart. The fourth liter of CELSIOR was infused 
directly before the implantation [11]. 
Statistical techniques
Statistical analysis was performed using STATISTICA 
8.0 software. First, the type of the variables’ distribution 
was assessed using basic statistical packages. Because all 
the analyzed parameters had the distribution distant from 
the normal one, non-parametric tests were used. Mann–
Whitney and R Sperman tests were utilized. Results were 
described as arithmetic averages with statistical deviation. 
p < 0.05 was considered as statistically significant, p < 0.2 
was considered as the weak trend.
Results
On the following days after HTX (from day 0 to day 
3 after HTX) average troponin I levels were 20.4 ±13.8; 
19.7 ±13.8; 15.6 ±14.1; 12.5 ±9.5, respectively. 
can potentially  influence higher troponin I levels (no statistical 
significance).
Key words: heart transplantation, troponin, donor’s heart.
plantacji serca. Istotna statystycznie ujemna korelacja wymaga 
dalszej analizy. Wpływ na wyższe wartości troponiny może mieć 
wiek dawcy oraz udar mózgu jako przyczyna zgonu dawcy.
Słowa kluczowe: przeszczep serca, troponina I, serce dawcy.
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There was an inverse correlation between TIT (mean 
218.8 min ±44.2) and troponin I levels was noted in the pe-
riod between day 0 and day 2 after HTX; p < 0.05 (on the 
3rd day – weak trend; r =  –0.3; p = 0.16) (R Sperman test) 
(Table I).
We have not found any influence of vasopressants (do-
pamine/dobutamine, norepinephrine) on troponin I levels 
(Mann–Whitney test) (Table II).
The weak trend (r = 0.3; p = 0.17) to positive correla-
tion between donor’s age (mean 33.9 ±13.9) and troponin I 
levels on the 1st day after HTX (R Sperman test) was obse-
rved (Table III).
A similar weak trend (p = 0.16) was observed in the 
correlation between stroke and higher levels of troponin I 
levels on the 1st day (Mann–Whitney test) (Table IV).
Discussion
Analysis of interdependence between troponin I levels 
and TIT on the consecutive days after HTX surprisingly sho-
wed the negative correlation. Data from the literature did 
not define the explicit correlation between TIT and troponin 
levels after HTX. Halwachs et al. did not find any correlation 
between TIT and troponin levels [9]. Similar lack of relation-
ship was shown  by Zimmermann et al. [10]. However, Ryan 
et al. in their experimental study noted a strong correlation 
between ischemic time and amount of troponin released 
after heart transplantation [8]. Also annual ISHLT registry 
points out to TIT as a risk factor for 1-year mortality [3]. Re-
verse correlation observed in our study (lower troponin levels 
observed during longer TIT) does not prove a “protective ef-
fect” of ischemic time prolongation, which seems obvious. 
One paper documented an unexpected higher risk of prima-
ry graft failure connected with very short ischemic time (in 
our study mean TIT = 218.8 min ±44.2, which was consistent 
with a generally accepted normal value of TIT < 4 hours) [12]. 
We aimed to examine the supplementary hypothesis: 
because longer ischemic time is often connected with pro-
longed reperfusion time (i.e. time from aortic declamping 
to stopping cardiopulmonary bypass), most probably longer 
reperfusion time may have had a “protective” effect and 
be the cause of lower troponin I levels in the patients with 
longer TIT. However, in our study group we did not find any 
significant correlation between TIT and reperfusion time 
(r = –0.1; p = 0.5) (additional data not shown in results). 
In our centre, reperfusion time in the patients after HTX 
dependent de facto on the moment when the transplanted 
heart starts to perform a hemodynamically effective func-
tion. An explanation of the reverse correlation between 
TIT and troponin values may be the acceptance of longer 
ischemic time, mainly due to low risk donors dedicated to 
“good” recipient (i.e. without pulmonary hypertension), 
which may limit perioperative graft injury but analysis of 
that hypothesis was not the purpose of our study [4, 9]. The 
described correlation requires further multivariate analysis 
on a greater material. At that stage we can only conclu-
de about the lack of a direct risk of troponin level increase 
with TIT prolongation, with its average of less than 4 hours 
(main 218.8 min ±44.2).
Statistical analysis showed the presence of a weak trend 
towards higher troponin I levels, when the cardiac donor’s 
death was caused by stroke (in comparison with injury). Bra-
in death is related with the two important stage factors my-
Tab. I. Analysis of the correlation between total ischemic time 
(TIT) and troponin I levels on the following days after HTX (trop0 
– troponin I on day 0; trop1 – troponin I on day 1, trop2 – troponin 
I on day 2, trop3 – troponin I on day 3 after HTX) (R Sperman test)
TIT (min)
Trop0 p = 0.03* r = –0.4
Trop1 p = 0.03* r = –0.4
Trop2 p = 0.01* r = –0.5
Trop3 p = 0.16** r = –0.3
*statistically significant reverse correlation; higher TIT correlates with lower 
values of trop0, trop1, trop2; **statistical trend; higher TIT correlates with lower 
trop3 values.
Tab. II. Analysis of the interdependence between vasopressors’ 
use in the donor (DM/DB – dopamine and/or dobutamine, NOR 
– norepinephrine , “+” – presence, “–” – absence) and troponin I 
levels after HTX (trop0 – troponin I on day 0; trop1 – troponin I on 
day 1, trop2 – troponin I on day 2, trop3 – troponin I on day 3 after 
HTX) (Mann–Whitney test)
DM/DB +
NOR +
DM/DB –
DM/DB +
NOR + 
NOR –
DM/DB + 
NOR –
Trop0 p = 0.46 p = 0.91 p = 0.32 p = 0.89
Trop1 p = 0.33 p = 0.70 p = 0.21 p = 1.0 
Trop2 p = 0.96 p = 0.44 p = 0.54 p = 0.63
Trop3 p = 0.31 p = 0.84 p = 0.21 p = 0.57
Tab. III. Analysis of interdependence between donor’s age (D AGE) 
and troponin I levels on the following days after HTX (trop0 – tro-
ponin I day 0; trop1 – troponin I on day 1, trop2 – troponin I on day 
2, trop3 – troponin I on day 3 after HTX) (R Sperman test)
D AGE (years)
Trop0 p = 0.52 r = 0.1
Trop1 p = 0.17* r = 0.3
Trop2 p = 0.36 r = 0.2
Trop3 p = 0.79 r = 0.1
*statistical trend; higher donor’s age correlates with higher trop1 levels.
Tab. IV. Analysis of interdependence between donor’s death cause 
(INJ – trauma, STR – stroke) and troponin I levels on the following 
days after HTX (trop0 – troponin I on day 0; trop1 – troponin I on 
day 1, trop2 – troponin I on day 2, trop3 – troponin I on day 3 after 
HTX) (Mann-Whitney test)
INJ/STR
Trop0 p = 0.41
Trop1 p = 0.16*
Trop2 p = 0.22
Trop3 p = 0.46
*statistical trend; STR is connected with higher trop1 level.
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ocardial damage: 1. catecholamine storm causes vasocon-
striction, tachycardia, which promotes myocardial ischemia, 
2. urgent vasodilatation, which lowers coronary perfusion, 
augments myocardial ischemia. The mechanism of brain de-
ath may potentially influence the dynamics of the described 
processes [4]. However, ISHLT Registry data show no influ-
ence of the cause of death on 1-year mortality [3]. But as we 
know, stroke is often connected with arterial hypertension 
and uncontrolled hypertension leads to myocardial hypertro-
phy. Left ventricular hypertrophy of the donor may handicap 
graft protection and according to actual guidelines, it is an 
important risk factor for graft failure [4, 13].
The weak trend towards the higher troponin levels on the 
first day after HTX correlating with older donor’s age was 
observed. Donor’s age is a known risk factor for early graft 
failure. The obligatory guidelines recommend (class IIa) ac-
cepting donors aged up to 45 years, older donors could be 
accepted only under special additional conditions [3, 14].
In the presented material, the average donor’s age was 
< 34 years, so it was the “safe age”, which could result in 
the lack of the significant influence of donor’s age on the 
extent of perioperative myocardial injury.
Also, vasopressor influence on the dynamics of troponin 
I levels after HTX was studied. Because of the logistic dif-
ficulties it was impossible to follow reliably the dosage of 
vasopressive agents that the heart donor was given (doses 
were modified many times during long-term infusion). So 
only the usage of selected drugs (dopamine/dobutamine, 
norepinephrine) on troponin levels after HTX was analysed. 
No relation of the mentioned drugs on troponin I values 
on the following days after HTX was noted. Although, it is 
known that high vasopressant doses may be the cause of 
early graft failure [15].
In our material, hearts demanding intensive pharma-
cological support were avoided. The decisions were made 
individually without any general scheme.
During analysis of troponin levels after HTX, a question 
about the influence of troponin values in the donor’s heart 
can be asked. Reliable values of troponin in the heart do-
nor were impossible to obtain due to technical problems (no 
measurement, no general scheme of troponin levels moni-
toring, different troponin types: I or T). Analysis by Khush et 
al. did not show any influence of elevated troponin levels in 
the heart donor on higher risk of recipient mortality or need 
for post-transplant mechanical circulatory support [16].
Study limitations:
• retrospective analysis based on archive data,
• limited number of the study group,
• limited number of analysed factors potentially influen-
cing dynamics of troponin levels after HTX,
• impossibility of gaining reliable data concerning donor 
heart function after of the brain death,
• impossibility of univocal comparison of the literature 
data because of different types of troponin used (I or T),
• replacement of the previously used troponin I for high-
ly sensitive troponin T (in 2010) in the authors’ centre, 
which complicates prospective analysis.
Conclusion
TIT does not correlate positively with increasing troponin I 
levels on the first days after HTX. Statistically significant in-
verse correlation demands further analysis. The following 
factors may influence higher troponin levels: donor’s age 
and stroke as the cause of death (weak trend).
The study was conducted upon the agreement of the Lo-
cal Bioethical Committee (KBET/224/B/2010).
This work was supported by a grant from the Ministry of 
Science and Higher Education through the Jagiellonian Uni-
versity Medical College K/ZDS/002427
References
1. Sadowski J, Przybyłowski P, Wierzbicki K. Leczenie chirurgiczne niewydol-
ności serca. W: Podolec P, Jankowska J, Ponikowski P. Przewlekła niewydol-
ność serca. Wyd. 1. Medycyna Praktyczna, Kraków 2009, 469-481.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-
Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Me-
bazaa A, Nieminen M, Priori SG, Swedberg K; ESC Comimittee for Practice 
Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute 
and chronic heart failure 2008: the Task Force for the diagnosis and treat-
ment of acute and chronic heart failure 2008 of the European Society of 
Cardiology. Developed in collaboration with the Heart Failure Association 
of the ESC (HFA) and endorsed by the European Society of Intensive Care 
Medicine (ESICM) Eur J Heart Fail 2008; 10: 933-989. 
3. www.ishlt.org
4. Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, 
Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, 
Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, 
Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, 
Zuckermann A, Hunt S, Burch M, Bhat G, Canter C, Chinnock R, Crespo-Leiro 
M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, 
Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, 
Keogh A, Lewis C, O’Connell J, Rogers J, Ross H, Russell S, Vanhaecke J; In-
ternational Society of Heart and Lung Transplantation Guidelines. The Inter-
national Society of Heart and Lung Transplantation Guidelines for the care 
of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914-956.
5. Solnica B. Badania laboratoryjne. W: Szczeklik A (red.). Choroby Wewnętrz-
ne. Wyd. 2. Medycyna Praktyczna, Kraków 2010; 26-34.
6. Stępień E, Śnieżek-Maciejewska M, Szajna-Zych M, Sadowski J. Biochemicz-
ne markery niedokrwienia mięśnia sercowego w diagnostyce zawału około-
operacyjnego uszkodzenia serca. Forum Kardiologów 2002; 7: 135-142.
7. Piątkowski R, Filipiak KJ, Zieliński A, Bobilewicz D, Opolski G. Troponiny 
w diagnostyce martwicy mięśnia sercowego. Terapia 2001; 111: 53.
8. Ryan JB, Hicks M, Cropper JR, Garlick SR, Kesteven SH, Wilson MK, Feneley 
MP, Macdonald PS. The initial rate of troponin I release post-reperfusion 
reflects the effectiveness of myocardial protection during cardiac allograft 
preservation. Eur J Cardiothorac Surg 2003; 23: 898-906.
9. Halwachs G, Iberer F, Pieber T, Müller H, Tscheliessnigg K, Tiran A, Sabin K, 
Wilders-Truschnig M. Troponin T as a marker for posttransplantation ad-
aptational problems of the donor heart. J Heart Lung Transplant 1996; 
15: 451-455.
10. Zimmermann R, Baki S, Dengler TJ, Ring GH, Remppis A, Lange R, Hagl S, 
Kübler W, Katus HA. Troponin T release after heart transplantation. Br Heart 
J 1993; 69: 395-398.
11. Wierzbicki K, Sobczyk D, Milaniak I, Bochenek M, Piątek J, Drwiła R, Kapelak B, 
Krupa F, Przybyłowski P, Ciołczyk-Wierzbicka D, Sadowski J. Dynamika zmian 
stężeń troponiny I w pierwszych dobach po przeszczepieniu serca (HTX) 
w materiale własnym – pilot study. Kardiochir Torakochir Pol 2011; 8: 379-382.
12. Russo MJ, Iribarne A, Hong KN, Ramlawi B, Chen JM, Takayama H, Mancini 
DM, Naka Y. Factors associated with primary graft failure after heart trans-
plantation. Transplantation 2010; 90: 444-450.
13. Januszewicz A, Prejbisz A. Nadciśnienie tętnicze. W: Szczeklik A (red.). Choro-
by Wewnętrzne. Wyd. 2. Medycyna Praktyczna, Kraków 2010; 335-350.
14. Young JB, Hauptman PJ, Naftel DC, Ewald G, Aaronson K, Dec GW, Taylor 
DO, Higgins R, Platt L, Kirklin J. Determinants of early graft failure following 
Kardiochirurgia i Torakochirurgia Polska 2011; 8 (4)520
 Influence of selected donor characteristics on the troponin I levels after heart transplantation: a single centre experience  
cardiac transplantation, a 10-year, multi-institutional, multivariable analy-
sis. J Heart Lung Transplant 2001; 20: 212.
15. Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodehef-
fer RJ, Kenzora JL. Matching the heart donor and heart transplant recipient. 
Clues for successful expansion of the donor pool: a multivariable, multiin-
stitutional report. The Cardiac Transplant Research Database Group. J Heart 
Lung Transplant 1994; 13: 353-364.
16. Khush KK, Menza RL, Babcock WD, Zaroff JG. Donor cardiac troponin I levels 
do not predict recipient survival after cardiac transplantation. J Heart Lung 
Transplant 2007; 26: 1048-1053.
